Stock Financial Ratios


BIVV / Bioverativ Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price64.11
Volume829,100.00
Market Cap ($M)6,767.95
Enterprise Value ($M)6,590.55
Book Value ($M)0.00
Book Value / Share0.00
Price / Book9.08
NCAV ($M)0.00
NCAV / Share0.00
Price / NCAV-53.76
Income Statement (mra) ($M)
Revenue0.00
EBITDA0.00
Net Income0.00
Balance Sheet (mrq) ($M)
Cash & Equivalents224.10
Cash / Share0.00
Assets1,453.50
Liabilities703.20
Quick Ratio0.00
Current Ratio0.00
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.00
Return on Assets (ROA)0.00
Return on Equity (ROE)0.00
Identifiers and Descriptors
CUSIP09075E100
Central Index Key (CIK)1681689
Industry Groups
Share Statistics
Common Shares Outstanding (M)108.20
Scoring Models
Piotroski F Score0.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash Per Share0.00
Debt Per Share0.00
Assets Per Share0.00
Inventory Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Liabilities Current Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Retained Earnings Per Share0.00
Equity Per Share0.00
Assets Current Per Share0.00
Minority Interest Per Share0.00
Inventory Work In Progress Per Share0.00

Related News Stories

Sanofi Is Damned If It Doesn't and Damned If It Does - Bloomberg

13m bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (65-0)

Sanofi CEO Delivers $11.6 Billion Deal After Striking Out Twice - Bloomberg

2h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (100-0)

Bioverativ Inc Stock Gets 64% Premium in Acquisition by Sanofi | InvestorPlace

3h investorplace
Biotech company Bioverativ Inc (NASDAQ:BIVV) is being acquired by Sanofi SA (ADR) (NYSE:SNY) for $11.6 billion in cash. The deal puts a 64% premium on the price of BIVV stock, which was up 61% in pre-market activity at 5:15 a.m. today. (83-0)

Global Stocks Muted After U.S. Government Shutdown - WSJ

5h wsj
Global stock markets were muted on Monday as a U.S. federal government shutdown was poised to stretch into a third day. (48-0)

Healthcare group Sanofi agrees to buy U.S. peer Bioverativ for $11.6 billion

6h reuters
PARIS (Reuters) - French healthcare group Sanofi has agreed to buy U.S. peer Bioverativ for $11.6 billion, in a deal which Sanofi said would boost its earnings and strengthen its presence in the field of treatments for rare diseases. (33-0)

CUSIP: 09075E100